Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects

January 2009
BMC Psychiatry;2009, Vol. 9, p57
Academic Journal
No abstract available.


Related Articles

  • Serum Glutathione in Patients with Schizophrenia in Dynamics of Antipsychotic Therapy. Ivanova, S.; Smirnova, L.; Shchigoreva, Yu.; Semke, A.; Bokhan, N. // Bulletin of Experimental Biology & Medicine;Dec2015, Vol. 160 Issue 2, p283 

    Serum concentrations of oxidized and reduced glutathione were measured in 73 patients with schizophrenia at admission and in dynamics of therapy with traditional and atypical antipsychotic drugs. The level of reduced glutathione in patients with schizophrenia with manifest clinical symptoms was...

  • Weight Gain, Schizophrenia and Antipsychotics: New Findings from Animal Model and Pharmacogenomic Studies. Panariello, Fabio; De Luca, Vincenzo; de Bartolomeis, Andrea // Schizophrenia Research & Treatment;2011, p1 

    Excess body weight is one of the most common physical health problems among patients with schizophrenia that increases the risk for many medical problems, including type 2 diabetes mellitus, coronary heart disease, osteoarthritis, and hypertension, and accounts in part for 20% shorter life...

  • Atypical antipsychotics not associated with improved hospitalisation outcomes compared with typical antipsychotics in people with schizophrenia in real practice. Taylor, David // Evidence Based Mental Health;May2013, Vol. 16 Issue 2, p36 

    The article discusses the effectiveness and cost of atypical versus typical antipsychotic treatment in people with schizophrenia in real practice. It mentions that mean treatment costs were more for atypical antipsychotics compared with typical antipsychotics. The result of the study showing no...

  • cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects. Sondhi, S.; Castellano, J. M.; Chong, V. Z.; Rogoza, R. M.; Skoblenick, K. J.; Dyck, B. A.; Gabriele, J.; Thomas, N.; Ki, K.; Pristupa, Z. B.; Singh, A. N.; MacCrimmon, D.; Voruganti, P.; Foster, J.; Mishra, R. K. // Pharmacogenomics Journal;2006, Vol. 6 Issue 2, p131 

    Clozapine is an atypical antipsychotic drug with unique pharmacological and therapeutic properties. Unlike the typical antipsychotic drug, haloperidol, clozapine does not cause extrapyramidal side effects; however, weight gain, dyslipidemia, and type II diabetes are commonly associated with the...

  • New drugs for schizophrenia: An update for family physicians. Amadio, Patricia B.; Cross, L. Brian // American Family Physician;9/15/1997, Vol. 56 Issue 4, p1149 

    Discusses therapeutic uses of drugs for schizophrenia. Pathophysiology of schizophrenia; Standard antipsychotic drug therapy; Atypical antipsychotic drug therapy.

  • Atypical antipsychotic drugs cut negative symptoms, side effects. Zablocki, Elaine // Managed Healthcare Executive;Mar2004, Vol. 14 Issue 3, p48 

    Examines the efficacy of atypical antipsychotic drugs on the treatment of schizophrenia in the U.S. Percentage of the American population affected by Schizophrenia; List of conventional antipsychotics and their side effects; Variation of approriate dosage and choice of antipsychotics from...

  • The effects of ziprasidone on regional c-Fos expression in the rat forebrain. Jennings, C. A.; Cluderay, J. E.; Gartlon, J.; Cilia, J.; Lloyd, A.; Jones, D. N. C.; Southam, E. // Psychopharmacology;Jan2006, Vol. 184 Issue 1, p13 

    Rationale: Typical and atypical antipsychotic drugs produce characteristic patterns of immediate early gene expression in rat forebrain that are considered to reflect their effects in schizophrenia subjects. Objective: To use c-Fos immunohistochemistry to investigate the functional...

  • Newer Antipsychotic Drugs and Sudden Death. DiMarco, John P. // Clinical Cardiology Alert;Mar2009, Vol. 28 Issue 3, p19 

    Ray et al examined the computerized files of Tennessee Medicaid recipients to estimate the effects of atypical antipsychotic drugs on the risk of sudden cardiac death. It is well known that typical antipsychotic drugs (for example, thioridazine or haloperidol) block potassium currents in vitro...

  • Paliperidone Extended-Release: Safety and Tolerability from a Metabolic Profile Perspective. Rodríguez-Martínez, Alfonso; Quilo, Carlos Guzmán // Clinical Drug Investigation;Dec2013, Vol. 33 Issue 12, p867 

    Pharmacologic management strategies for schizophrenia, a relatively common psychotic disorder, include the use of typical and atypical antipsychotic drugs. In general, typical (or conventional) antipsychotics have a proven track record in effectively managing the positive symptoms of...

  • Ziprasidone: zealous in the treatment of schizophrenia and schizoaffective disorder.  // Drugs & Therapy Perspectives;Apr2003, Vol. 19 Issue 4, p1 

    Ziprasidone is a novel atypical antipsychotic with a different pharmacological profile from that of other currently available typical and atypical antipsychotics. It is markedly effective, and apparently at least as effective as haloperidol and olanzapine, in patients with acute exacerbations of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics